Good morning, folks. Another shiny day is unfolding here on the chilly Pharmalot corporate campus, where the dogs are barking and the short people are scrambling off to the school houses. As for us, we are downing a cup of stimulation - our flavor today is Golden French Toast - and hunting for interesting tidbits. Hear something fascinating? Do pass it our way. Meanwhile, here are a few items to help you along. Hope your day goes well...
Eli Lilly And Boehringer Ink Diabetes Drug Deal (Reuters)
Merck Cut Global Salesforce By 12 Percent In 2010 (Dow Jones)
Amgen Moves Three Cancer Drugs Into Late-Stage Tests (Bloomberg News)
Neurosearch Cuts Workforce By 20 Percent (Reuters)
Prozac May Speed Physical Rehab After Stroke: Study (HealthDay)
Swine Flu Survivors Developed Super Flu Antibodies (Reuters)
HGS Hopes To Bank Billions After Lupus Drug Launches (PharmaTimes)
Aurobindo Sells Ingredient Unit To Sinopharm (InPharma Technologist)
Statins May Be Harmful After Stroke (HealthDay)
Shire Sees Vyvanse Used For Excessive Sleepiness Disorder (IBTimes)